A Phase 1 Dose Escalation and Expansion Study of OMP-305B83 in Subjects With Solid Tumors

This trial is no longer accepting participants. To get information / assistance in finding a clinical study that is right for you, please call Cancer AnswerLine at 800-865-1125.